SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-035914
Filing Date
2024-03-25
Accepted
2024-03-25 16:07:38
Documents
14
Period of Report
2024-03-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K prok-20240325.htm   iXBRL 8-K 47992
2 EX-10.1 prok-ex10_1.htm EX-10.1 74030
3 EX-99.1 prok-ex99_1.htm EX-99.1 15388
4 GRAPHIC img22993735_0.jpg GRAPHIC 3479
  Complete submission text file 0000950170-24-035914.txt   282738

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT prok-20240325.xsd EX-101.SCH 25827
17 EXTRACTED XBRL INSTANCE DOCUMENT prok-20240325_htm.xml XML 4900
Mailing Address 2000 FRONTIS PLAZA BLVD. SUITE 250 WINSTON-SALEM NC 27103
Business Address 2000 FRONTIS PLAZA BLVD. SUITE 250 WINSTON-SALEM NC 27103 336-999-7028
PROKIDNEY CORP. (Filer) CIK: 0001850270 (see all company filings)

IRS No.: 981586514 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40560 | Film No.: 24779271
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)